Journal of mental deficiency research 1982-06-01

A strategy for glycine encephalopathy therapy.

I S Mendelson

Index: J. Ment. Defic. Res. 26 (Pt 2) , 107-10, (1982)

Full Text: HTML

Abstract

An inherited defect in the glycine cleavage enzyme results in the condition of neonatal glycine encephalopathy which has not responded to the current innovative methods of therapy. A re-examination of the enzyme structure and metabolic pathways, leads us to recommend future clinical evaluation of (1) vitamin-responsiveness, e.g., pyridoxine, folate and lipoic acid, (2) methionine, (3) N5, N10-methylene tetrahydrofolate and (4) alpha-methylserine therapy during the critical period of neonatal brain growth and development.

Related Compounds

Related Articles:

Drug design, in vitro pharmacology, and structure-activity relationships of 3-acylamino-2-aminopropionic acid derivatives, a novel class of partial agonists at the glycine site on the N-methyl-D-aspartate (NMDA) receptor complex.

2009-08-27

[J. Med. Chem. 52 , 5093-107, (2009)]

The requirement of phosphorylation on a threonine residue in the acute regulation of steroidogenesis in MA-10 mouse Leydig cells.

1993-09-01

[J. Steroid Biochem. Mol. Biol. 46(3) , 337-47, (1993)]

Control of chemoselectivity in Dieckmann ring closures leading to tetramic acids.

2011-10-07

[Org. Biomol. Chem. 9 , 6663, (2011)]

Synthesis, NMR spectra and function of peptides with alpha-methylserine attached to the RGD sequence of osteopontin.

1992-10-01

[Acta Chem. Scand. 46(10) , 989-93, (1992)]

Conformational studies on host-guest peptides containing chiral alpha-methyl-alpha-amino acids. Comparison of the helix-inducing potential of alpha-aminoisobutyric acid, (S)-2-ethylalanine and (S)-2-methylserine.

1988-11-01

[Int. J. Pept. Protein Res. 32(5) , 344-51, (1988)]

More Articles...